Cost-Effectiveness of Metacognitive Therapy for Cardiac Rehabilitation
Study Overview
The study examines the effectiveness and cost of metacognitive therapy (MCT) combined with usual care (UC) for patients with cardiovascular disease (CVD) experiencing anxiety and/or depression. The goal is to see if MCT is a better option than just UC.
Research Method
A multicenter, single-blind, randomized controlled trial was conducted in the UK with 332 patients. The main focus was on measuring quality-adjusted life-years (QALYs) over a 12-month period. Various methods were used to ensure accurate data analysis.
Key Findings
The results showed that MCT was cost-effective, saving approximately £219 while also improving QALYs by 0.015. However, there is some uncertainty in these results. At a cost threshold of £30,000 per QALY, MCT has a 76% chance of being cost-effective.
Conclusions
The findings suggest that MCT could save costs and improve health outcomes, but further research is needed to confirm these results and explore long-term benefits.
Importance of Clinical Trials
Clinical trials are essential for developing safe and effective treatments. It’s crucial to integrate their findings into everyday medical practice.
Practical Solutions
DocSym, our AI-driven platform, simplifies access to ICD-11 standards, clinical protocols, and research, making it easier for clinicians to find the information they need.
Enhancing Healthcare Operations
Our mobile apps facilitate scheduling, treatment monitoring, and telemedicine, streamlining patient care and expanding digital services.
Improving Patient Outcomes
By leveraging AI, clinics can enhance workflows, improve patient outcomes, and reduce reliance on paper processes. Discover more at aidevmd.com.
